Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
9342-8530 Quebec Inc
DGCRF
Healthcare
Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:DGCRF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
oceanblvd
X
View Profile
View Bullboard History
Post by
oceanblvd
on Dec 17, 2014 9:09am
20% holder
It was annouced yesterday that investor Todd Axelrod accquired an additional 4,255,500 shares bringing ownership to over 8.5 million shares. he has been a very successful investor in the past and one
...more
(0)
•••
Kondero
X
View Profile
View Bullboard History
Comment by
Kondero
on Dec 13, 2014 10:58am
RE:Richard Ablin: Great Prostate Hoax
From the discoverer of the PSA gene , that testimony is highly impressive and corroborate the fact that the PSA test is now a way, for many unscrupulous people, to make a lot of money. Fantomatus
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Dec 13, 2014 10:15am
Richard Ablin: Great Prostate Hoax
The Problem With Prostate Screening By RICHARD J. ABLIN Continue reading the main story Continue reading the main storyShare This Page
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Dec 13, 2014 10:07am
To screen or not..?
To the Editor: Re “The Problem With Prostate Screening” (Op-Ed, Nov. 26): We were disheartened to read Dr. Richard J. Ablin accuse us, as investigators of the European
...more
(0)
•••
Kondero
X
View Profile
View Bullboard History
Comment by
Kondero
on Nov 29, 2014 10:25am
RE:The last obstacles
Erratum: in my previous post, first line, instead of 'outsider' please read 'insider' . Fantomatus
(0)
•••
Kondero
X
View Profile
View Bullboard History
Post by
Kondero
on Nov 27, 2014 10:52am
The last obstacles
Hard to understand ( impossible should I say ) what is really going on without being an outsider. But some good news can be seen forward : 1- décisions from Medicare and Medicaid about
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Nov 17, 2014 11:35am
Volume!
What's National positioning itself for? 11/17/2014 11:09 AM EST 0.115 200,000 0.01 TSX 080 080 11/17/2014 11:09 AM
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Oct 30, 2014 5:49pm
Corporate Initiatives 2014
Wierd that there is no mention of Bordeleau. Is he still with us? Must be one unhappy guy as his options are worthless and his own investment in CUR has been cut in half. If he has been
...more
(0)
•••
oceanblvd
X
View Profile
View Bullboard History
Post by
oceanblvd
on Oct 08, 2014 3:08pm
truth
When will the board and fradet allow Mr. Bordeleau to give its stockholders an update on the company ? I believe he his the only one that can communicate properly
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Aug 31, 2014 11:33am
Q3 c.c. imminent
Will we hear from m. Bordeleau? This company needs a full-time CEO.
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Aug 10, 2014 11:26am
PC RiskCalculator: Updated
Revamped Prostate Cancer Risk Calculator Now Online Fran LowryAugust 08, 2014
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Jul 30, 2014 8:45pm
From HOLX Q3
Third Quarter Fiscal 2014 Revenue Overview by Segment (Compared to the Third Quarter Fiscal 2013): Diagnostics revenues of $293.1 million decreased (1.5)%, primarily due to decreases in ThinPrep
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Jun 23, 2014 9:12am
GCC Competitor?
Gene expression profiling test expands to assess colon and prostate cancers Kelly Grant - HEALTH REPORTER The Globe and Mail Published Last updated 4
...more
(0)
•••
Kondero
X
View Profile
View Bullboard History
Post by
Kondero
on Jun 18, 2014 10:42am
Just my opinion .000000000
Since almost two years, HOLX did'nt show any eagerness to make the PCA3 test flare up. Probably because that company is dedicated to women diseases above all. Nevertheless, its subsidiary
...more
(22)
•••
modulex
X
View Profile
View Bullboard History
Post by
modulex
on Jun 17, 2014 7:07pm
HOPE DIAGNOCURE WILL REBOUND FROM A NIGHTMARE TO A WINDFALL
DIAGNOCURE'S HISTORY HAS BEEN A STRING OF ROLLER COASTER NEWS. WITH $3M IN CASH THE PARTNERSHIP WITH SHUWEN BIOTECH MAY AVOID A POSSIBLE FINANCIAL CRUNCH. I THINK THAT THERE IS SOME
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up